Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML).
about
Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study.Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease.Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series reportRelationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetesVascular effects of advanced glycation end-products: content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease.Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness.Glycomic analysis of high density lipoprotein shows a highly sialylated particle.Molecular basis of arterial stiffening: role of glycation - a mini-review.RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.Decreased plasma sRAGE levels in COPD: influence of oxygen therapy
P2860
Q33752140-AC5871FC-EAFF-4A81-A845-3353AF8DA155Q34097974-6C451EA8-465B-472E-90F1-A0DFD5DC94E1Q34173840-7832DFF9-B0D0-485D-89D1-B6E49EFACEFDQ34437307-E3D7D423-0F70-4A57-9F03-7706882EFAB8Q34468219-D7B7B97D-CFDB-4F7B-ACAB-F30B5E0DF27DQ34556050-886B0FED-0BEA-40F8-856A-4B05F8EE1E45Q34993000-2C3F9E0F-438B-427A-8768-20EAB90CE2DFQ35234153-9226BD82-2F8C-482F-B6E3-932F13A3775CQ35783715-332298A4-A13C-4BBE-AFA0-8582204144AAQ37622708-3D674811-E6A8-465E-AD10-7ECDC055B33EQ37684531-B762D451-667C-462F-9833-BE04378568B2Q37973610-EE131B30-8F98-472C-B867-30A3857378BAQ42070405-63C47DB1-5A48-4BAF-A611-A53CD28F61E8Q57549422-0DB24168-7B0D-4112-9D09-596C0D6E828D
P2860
Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between carotid di ...... lon-carboxymethyllysine (CML).
@en
Association between carotid di ...... N-epsilon-carboxymethyllysine
@nl
type
label
Association between carotid di ...... lon-carboxymethyllysine (CML).
@en
Association between carotid di ...... N-epsilon-carboxymethyllysine
@nl
prefLabel
Association between carotid di ...... lon-carboxymethyllysine (CML).
@en
Association between carotid di ...... N-epsilon-carboxymethyllysine
@nl
P2093
P2860
P356
P1476
Association between carotid di ...... lon-carboxymethyllysine (CML).
@en
P2093
Daniel Sollinger
Hans-Henning Eckstein
Jaroslav Pelisek
Marcel Roos
Marcus Baumann
Tatiana Kouznetsova
Tom Richart
Uwe Heemann
P2860
P2888
P356
10.1186/1475-2840-8-45
P407
P577
2009-08-06T00:00:00Z
P5875
P6179
1042878357